CRP and hydrops fetalis: In a randomized clinical trial of 30 patients with acute decompensated HF, blockade of IL-1 with anakinra significantly reduced CRP level compared to the placebo, suggesting that anakinra suppresses the systemic inflammatory response in HF patients (Van Tassell et al., 2016).